NasdaqGS - Delayed Quote • USD
Legend Biotech Corporation (LEGN)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:10 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-393,276.00
-393,276.00
-201,281.00
-198,465.00
-223,005.00
Investing Cash Flow
92,786.00
92,786.00
-77,092.00
-194,983.00
-24,169.00
Financing Cash Flow
791,490.00
791,490.00
377,976.00
626,663.00
618,879.00
End Cash Position
1,277,713.00
1,277,713.00
786,031.00
688,938.00
455,689.00
Capital Expenditure
-22,722.00
-22,722.00
-22,275.00
-45,404.00
-30,283.00
Issuance of Capital Stock
583,688.00
583,688.00
377,643.00
623,440.00
622,535.00
Repayment of Debt
-3,755.00
-3,755.00
-2,596.00
-1,419.00
-2,602.00
Free Cash Flow
-415,998.00
-415,998.00
-223,556.00
-243,869.00
-253,288.00
12/31/2020 - 6/5/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BGNE BeiGene, Ltd.
153.58
+3.38%
BPMC Blueprint Medicines Corporation
93.00
+2.50%
GMAB Genmab A/S
28.15
+2.51%
APLS Apellis Pharmaceuticals, Inc.
49.86
+4.03%
ALNY Alnylam Pharmaceuticals, Inc.
143.31
-0.28%
ALXO ALX Oncology Holdings Inc.
16.86
-0.06%
ASND Ascendis Pharma A/S
135.90
-0.75%
APGE Apogee Therapeutics, Inc.
47.13
+2.77%
KRYS Krystal Biotech, Inc.
156.88
+0.77%
CYTK Cytokinetics, Incorporated
65.34
+0.83%